Jay Barth is Chief Medical Officer at AMICUS THERAPEUTICS, INC. (FOLD). They have made 21 open-market trades across 1 company since 2016, most recently 2020-09-30.
CIK 0001601896
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FOLD | 163,204 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2020-10-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FOLD | SELL | 2020-09-30 | 2020-10-02 | $14.51 | $118K | +21.1% | +31.0% | +70.5% |
| FOLD | SELL | 2020-08-31 | 2020-09-02 | $14.74 | $424K | -2.6% | -5.7% | +58.5% |
| FOLD | SELL | 2020-07-27 | 2020-07-29 | $15.05 | $452K | +6.1% | +2.8% | +31.8% |
| FOLD | SELL | 2020-07-09 | 2020-07-13 | $15.81 | $2.3M | -1.8% | -2.5% | +4.8% |
| FOLD | SELL | 2020-07-07 | 2020-07-09 | $15.91 | $7.7M | -6.3% | -3.4% | -6.3% |
| FOLD | SELL | 2020-06-29 | 2020-07-01 | $15.51 | $465K | -4.8% | -8.5% | -10.9% |
| FOLD | SELL · 10b5-1 | 2020-06-17 | 2020-06-17 | $13.47 | $26K | +20.3% | +17.7% | +7.7% |
| FOLD | SELL | 2020-01-15 | 2020-01-17 | $10.35 | $214K | -12.1% | +4.6% | +2.7% |
| FOLD | SELL | 2020-01-06 | 2020-01-08 | $9.33 | $313K | -0.2% | +4.7% | +3.1% |
| FOLD | SELL | 2020-01-02 | 2020-01-03 | $9.55 | $186K | +15.1% | -1.0% | +6.4% |
| FOLD | SELL | 2019-04-05 | 2019-04-08 | $14.20 | $710K | -10.8% | -7.8% | -17.9% |
| FOLD | SELL | 2019-02-25 | 2019-02-27 | $12.52 | $1.8M | +7.3% | +8.2% | -4.6% |
| FOLD | SELL | 2018-05-14 | 2018-05-15 | $14.04 | $70K | +7.1% | +11.3% | -3.0% |
| FOLD | SELL | 2018-04-12 | 2018-04-16 | $14.72 | $74K | -4.7% | +11.5% | +7.0% |
| FOLD | SELL | 2018-03-12 | 2018-03-13 | $15.05 | $75K | -7.7% | -3.9% | +0.7% |
| FOLD | SELL | 2018-01-23 | 2018-01-25 | $16.80 | $336K | +2.1% | -5.5% | -15.2% |
| FOLD | SELL | 2018-01-02 | 2018-01-04 | $14.71 | $74K | +1.9% | +2.5% | -11.9% |
| FOLD | SELL | 2017-12-01 | 2017-12-05 | $13.59 | $68K | +3.2% | +24.0% | +10.6% |
| FOLD | SELL | 2017-10-12 | 2017-10-16 | $14.25 | $71K | -8.8% | -12.6% | +2.2% |
| FOLD | SELL | 2017-06-19 | 2017-06-19 | $10.00 | $300K | +0.3% | +35.1% | +38.1% |
| FOLD | SELL | 2016-08-04 | 2016-08-08 | $7.00 | $73K | +4.6% | +5.2% | +10.9% |
| FOLD | SELL | 2016-07-27 | 2016-07-29 | $7.00 | $146K | -7.0% | +3.9% | +10.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.